Mon. 4 Mar 2024, 6:33am ET
Benzinga
Earnings, News
Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.29) by 10.34 percent. This is a 27.27 percent increase over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $19.45 million which beat the analyst consensus estimate of $18.11 million by 7.42 percent.